Research graph
References from Insulin‐reducing effect of adding imeglimin to ongoing dipeptidyl peptidase‐4 inhibitor therapy with multiple daily insulin injections ( INSPIRE study). Local targets link to admitted publications; unresolved targets remain external evidence.
10.1016/s2213-8587(24)00372-3
10.1016/s2213-8587(24)00372-3 · External reference
10.1185/03007995.2013.855187
10.1185/03007995.2013.855187 · External reference
10.1007/s13340-023-00651-z
10.1007/s13340-023-00651-z · External reference
10.1507/endocrj.k06-153
10.1507/endocrj.k06-153 · External reference
10.1177/08971900221134174
10.1177/08971900221134174 · External reference
10.2337/dc13-3055
10.2337/dc13-3055 · External reference
10.1111/jdi.13533
10.1111/jdi.13533 · External reference
10.1111/jdi.13636
10.1111/jdi.13636 · External reference
10.1007/s13340-021-00513-6
10.1007/s13340-021-00513-6 · External reference
Assessing the efficacy and safety of combined DPP‐4 inhibitor and insulin treatment in patients with type 2 diabetes: A meta‐analysis
2015 · External reference
10.1111/j.1463-1326.2012.01611.x
10.1111/j.1463-1326.2012.01611.x · External reference
10.1111/dom.14613
10.1111/dom.14613 · External reference
10.2147/dmso.s495930
10.2147/dmso.s495930 · External reference
10.1111/dom.14642
10.1111/dom.14642 · External reference
Unresolved reference
External reference
10.1002/dmrr.2924
10.1002/dmrr.2924 · External reference
10.1111/dom.15639
10.1111/dom.15639 · External reference
10.1007/s13300-023-01370-z
10.1007/s13300-023-01370-z · External reference
10.2337/dc20-0763
10.2337/dc20-0763 · External reference
10.1007/s00228-025-03902-x
10.1007/s00228-025-03902-x · External reference
10.1007/s40618-025-02655-9
10.1007/s40618-025-02655-9 · External reference
10.1186/s13098-025-01922-2
10.1186/s13098-025-01922-2 · External reference
10.1111/dom.15716
10.1111/dom.15716 · External reference
10.1111/jdi.14070
10.1111/jdi.14070 · External reference
10.1111/jdi.12773
10.1111/jdi.12773 · External reference
